ARENSIA EXPLORATORY MEDICINE   Report issue

For profit Phase 1 Phase 2
Founded: Dusseldorf Germany (2011)

Organization Overview

First Clinical Trial
2017
NCT03447756
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ARENSIA EXPLORATORY MEDICINE | ARENSIA Exploratory Medicine, Moldova

Active Ingredients

Drugs in Phase 2 Trials (2)

dimethyl fumarate (tecfidera) (1 trial)

imcy-0141 (1 trial)

Drugs in Phase 1 Trials (1)

abx-1431 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neuralgia (Phase 1)

Neuralgia, Postherpetic (Phase 1)

Peripheral Nervous System Diseases (Phase 1)

Small Fiber Neuropathy (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3